(Q44391224)

2 December 2017

title

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines (English)

1 reference

2 December 2017

1 reference

1 reference

1 reference

Schwarzer S

1

1 reference

2 December 2017

Reibel S

2

1 reference

2 December 2017

Lang AB

3

1 reference

2 December 2017

Struck MM

4

1 reference

2 December 2017

Finkel B

5

1 reference

2 December 2017

Gerike E

6

1 reference

2 December 2017

Tischer A

7

1 reference

2 December 2017

Gassner M

8

1 reference

2 December 2017

Glück R

9

1 reference

2 December 2017

Stück B

10

1 reference

2 December 2017

Cryz SJ Jr

11

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

2 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

2 December 2017

volume

16

1 reference

2 December 2017

issue

2-3

1 reference

2 December 2017

page(s)

298-304

1 reference

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Mumps meningitis following measles, mumps, and rubella immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Microassay of measles and mumps virus and antibody in VERO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900174-6

7 January 2021

10.1016/S0264-410X(97)00174-6

Identifiers

DOI

1 reference

2 December 2017

1 reference